Atea Pharmaceuticals Inc (AVIR)
3.705
-0.02
(-0.67%)
USD |
NASDAQ |
Apr 24, 16:00
3.705
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Price to Book Value: 0.5617 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 0.5655 |
| April 22, 2024 | 0.5564 |
| April 19, 2024 | 0.5639 |
| April 18, 2024 | 0.5609 |
| April 17, 2024 | 0.5624 |
| April 16, 2024 | 0.567 |
| April 15, 2024 | 0.57 |
| April 12, 2024 | 0.57 |
| April 11, 2024 | 0.5836 |
| April 10, 2024 | 0.5715 |
| April 09, 2024 | 0.5776 |
| April 08, 2024 | 0.57 |
| April 05, 2024 | 0.5776 |
| April 04, 2024 | 0.5836 |
| April 03, 2024 | 0.5912 |
| April 02, 2024 | 0.5867 |
| April 01, 2024 | 0.6064 |
| March 28, 2024 | 0.6124 |
| March 27, 2024 | 0.6064 |
| March 26, 2024 | 0.5715 |
| March 25, 2024 | 0.5791 |
| March 22, 2024 | 0.6155 |
| March 21, 2024 | 0.6215 |
| March 20, 2024 | 0.5988 |
| March 19, 2024 | 0.5973 |
| Date | Value |
|---|---|
| March 18, 2024 | 0.6064 |
| March 15, 2024 | 0.6079 |
| March 14, 2024 | 0.5836 |
| March 13, 2024 | 0.6049 |
| March 12, 2024 | 0.6064 |
| March 11, 2024 | 0.6109 |
| March 08, 2024 | 0.6064 |
| March 07, 2024 | 0.6185 |
| March 06, 2024 | 0.6109 |
| March 05, 2024 | 0.6049 |
| March 04, 2024 | 0.6124 |
| March 01, 2024 | 0.6746 |
| February 29, 2024 | 0.6534 |
| February 28, 2024 | 0.6625 |
| February 27, 2024 | 0.6913 |
| February 26, 2024 | 0.6549 |
| February 23, 2024 | 0.6312 |
| February 22, 2024 | 0.6056 |
| February 21, 2024 | 0.6327 |
| February 20, 2024 | 0.6507 |
| February 16, 2024 | 0.6192 |
| February 15, 2024 | 0.6327 |
| February 14, 2024 | 0.6041 |
| February 13, 2024 | 0.5861 |
| February 12, 2024 | 0.6222 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3903
Minimum
Mar 24 2023
13.31
Maximum
Feb 08 2021
1.983
Average
0.7384
Median
Mar 03 2022
Price to Book Value Benchmarks
| CEL-SCI Corp | 6.166 |
| AIM ImmunoTech Inc | 2.238 |
| IGC Pharma Inc | 3.034 |
| NovaBay Pharmaceuticals Inc | 1.644 |
| Protalix BioTherapeutics Inc | 2.644 |
Price to Book Value Related Metrics
| PS Ratio | 0.8794 |
| Price | 3.705 |
| Earnings Yield | -44.26% |
| Market Cap | 311.83M |
| Operating PE Ratio | 2.233 |
| Normalized PE Ratio | 2.724 |